ZA974809B - Live attenuated RTX-producing bacteria of the family pasteurellaceae. - Google Patents

Live attenuated RTX-producing bacteria of the family pasteurellaceae.

Info

Publication number
ZA974809B
ZA974809B ZA9704809A ZA974809A ZA974809B ZA 974809 B ZA974809 B ZA 974809B ZA 9704809 A ZA9704809 A ZA 9704809A ZA 974809 A ZA974809 A ZA 974809A ZA 974809 B ZA974809 B ZA 974809B
Authority
ZA
South Africa
Prior art keywords
producing bacteria
live attenuated
family pasteurellaceae
rtx
attenuated rtx
Prior art date
Application number
ZA9704809A
Other languages
English (en)
Inventor
Ruud Philip Antoon Mari Segers
Joachim Frey
Johannes Franciscus Bosch Den
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA974809B publication Critical patent/ZA974809B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/21—Haemophilus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA9704809A 1996-05-31 1997-05-30 Live attenuated RTX-producing bacteria of the family pasteurellaceae. ZA974809B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201557 1996-05-31

Publications (1)

Publication Number Publication Date
ZA974809B true ZA974809B (en) 1998-01-23

Family

ID=8224047

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704809A ZA974809B (en) 1996-05-31 1997-05-30 Live attenuated RTX-producing bacteria of the family pasteurellaceae.

Country Status (11)

Country Link
US (1) US6770275B1 (xx)
JP (1) JPH1075774A (xx)
KR (1) KR970074928A (xx)
CN (1) CN1117862C (xx)
AU (1) AU720156B2 (xx)
CA (1) CA2206575A1 (xx)
HU (1) HU226219B1 (xx)
MX (1) MX9704061A (xx)
NZ (1) NZ314987A (xx)
TW (1) TW546147B (xx)
ZA (1) ZA974809B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1860117A3 (en) * 1999-04-09 2008-09-03 Pharmacia & Upjohn Company LLC Anti-bacterial vaccine compositions
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
KR100807844B1 (ko) * 2006-12-27 2008-02-27 주식회사 바이오리쏘스 약독화된 파스튜렐라 물토시다 균주, 그를 포함하는면역원성 조성물 및 그를 이용한 포유동물의 파스튜렐라물토시다 감염증의 치료 또는 예방하는 방법
WO2009033024A1 (en) * 2007-09-05 2009-03-12 Genentech, Inc. Biologically active c-terminal arginine-containing peptides
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
EP3689373A1 (en) * 2019-01-30 2020-08-05 IDT Biologika GmbH Inactivated apxia, apxiia and apxiiia toxins

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963487A (en) * 1985-01-03 1990-10-16 Massachusetts Institute Of Technology Method for deletion of a gene from a bacteria
US5165924A (en) 1986-01-22 1992-11-24 University Of Guelph Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle
GB8611832D0 (en) * 1986-05-15 1986-06-25 Holland I B Polypeptide
US5256415A (en) 1989-03-20 1993-10-26 Louisiana State University Vaccine against bovine respiratory disease (pasteurellosis)
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
US5641653A (en) 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin
CA2045950C (en) * 1991-06-28 2004-05-11 Elbarte M. Kamp Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
CA2186121A1 (en) * 1994-03-22 1995-09-28 Robert Gerard Ankenbauer Pasteurellaceae antigens and related vaccines
AU717773B2 (en) * 1995-11-02 2000-03-30 Commonwealth Scientific And Industrial Research Organisation Immunity against pasteurella haemolytica leukotoxin
AUPN631495A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(I)
AUPN631395A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(II)

Also Published As

Publication number Publication date
HU9700975D0 (en) 1997-07-28
TW546147B (en) 2003-08-11
KR970074928A (ko) 1997-12-10
NZ314987A (en) 2000-02-28
CA2206575A1 (en) 1997-11-30
HUP9700975A3 (en) 2007-05-29
AU2464397A (en) 1997-12-04
US6770275B1 (en) 2004-08-03
HU226219B1 (en) 2008-06-30
HUP9700975A2 (hu) 1998-05-28
MX9704061A (es) 1998-04-30
JPH1075774A (ja) 1998-03-24
CN1117862C (zh) 2003-08-13
AU720156B2 (en) 2000-05-25
CN1173540A (zh) 1998-02-18

Similar Documents

Publication Publication Date Title
EP0683022A3 (en) Water repellant compositions.
GR950100048A (en) Improved remote gaming system.
EP0683465A3 (en) Medical network with remote access.
ZA974523B (en) Endoscopes.
IL125308A0 (en) Disinfecting compositions
IL136455A0 (en) Attenuated invasive bacteria
ZA200007642B (en) Treatment of airborne microorganisms.
ZA932689B (en) Disinfectant compositions.
GR3034796T3 (en) Acidic cleaning compositions.
ZA979280B (en) Cleaning compositions.
ZA971677B (en) Cleaning compositions comprising endo-dextranase.
HUP9800855A3 (en) Live attenuated bacteria of the species actinobacillus pleuropneumoniae
ZA974809B (en) Live attenuated RTX-producing bacteria of the family pasteurellaceae.
ZA971638B (en) Microbicidal composition.
GB2329126B (en) Disinfectant solutions
ZA973710B (en) Cleaning compositions.
EP0671500A3 (en) Compositions for the treatment of textiles.
ZA974221B (en) Water treatment compositions.
ZA969481B (en) Antimicrobial cleaning compositions.
GB2312047B (en) Improved pipework
AU2144499A (en) Live attenuated salmonella vaccine
FR2717357B1 (fr) Fauteuil de télévision.
IL130179A0 (en) Agricultural compositions containing bacteria
ZA9710499B (en) Longlines
GB2316684B (en) Degradatrive bacteria